Companies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...

The Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providin...

Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...

India Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Indoco Remedies' Goa plant received a warning letter from the USFDA following a July inspection. The company stated its commitment to resol...

Union minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...

These inspections come at a time when some of the largest Indian drug makers are still struggling with compliance procedures set by global ...

The suit states that Dr Reddy's repeatedly represented to Mezzion that it was compliant with FDA regulations, and that it hid its misconduc...

According to some GMP experts, CDSCO’s proposed move may be different from the risk-based inspection system followed by the US Food and Dru...

The industry has reaped the low-hanging fruits of low-cost generics, making Indian pharma companies one of the most profitable ones globall...

Wockhardt said the UK health regulator has completed inspection of its plant at Chikalthana without issuing any critical observations on th...

Shares of Sun Pharmaceutical Industries today fell by over 5 per cent after the US Food and Drug Administration banned import of drugs from...

Senior official of the country’s department of justice has dubbed the unravelling of a series of violations by the company over the past ei...

The government today said it has ordered the Drug Controller General of India (DCGI) to check the quality of drugs produced by Ranbaxy Labo...

"The reality at present is that the pharma stocks are always subject to problems with US FDA regulations," says Sajiv Dhawan of JV Capital.